Payment overview · 2025
General Payments
$18.70
1 reported records · 1 companies
Healthcare provider profile · identity verified
Chad Taylor Hott, FNP-BC
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · ROMNEY, WV · NPI 1669814950
Verified facts
What the public records show
CMS Open Payments records show Chad Taylor Hott, FNP-BC received $18.70 in general payments during 2025 across 1 reported records.
Janssen Pharmaceuticals, Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Janssen Pharmaceuticals, Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XARELTO as an associated drug or biological on 28 records involving 28 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Xarelto by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc | Unresolved — no canonical attribution shown | $18.70 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.70 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SPRAVATO Normalized: spravato |
Drug | Janssen Pharmaceuticals, Inc | $18.70 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc Exact reporting entity; no affiliate inference |
2025 | XARELTO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 28 recipient NPIs · example record 1174296970 |
Xarelto · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 511 | 158 |
| Lisinopril | Lisinopril | 505 | 145 |
| Levothyroxine Sodium | Levothyroxine Sodium | 492 | 133 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 417 | 139 |
| Tramadol Hcl | Tramadol Hcl | 412 | 90 |
| Pantoprazole Sodium | Pantoprazole Sodium | 399 | 111 |
| Amlodipine Besylate | Amlodipine Besylate | 382 | 124 |
| Alprazolam | Alprazolam | 355 | 52 |
| Gabapentin | Gabapentin | 347 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 282 | 89 |
| Montelukast Sodium | Montelukast Sodium | 252 | 63 |
| Omeprazole | Omeprazole | 238 | 75 |
| Duloxetine Hcl | Duloxetine Hcl | 228 | 54 |
| Furosemide | Furosemide | 211 | 56 |
| Metformin Hcl | Metformin Hcl | 211 | 67 |
| Potassium Chloride | Potassium Chloride | 204 | 52 |
| Famotidine | Famotidine | 201 | 52 |
| Losartan Potassium | Losartan Potassium | 182 | 49 |
| Meloxicam | Meloxicam | 176 | 54 |
| Fluticasone Propionate | Fluticasone Propionate | 168 | 62 |
| Simvastatin | Simvastatin | 167 | 47 |
| Eliquis | Apixaban | 166 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 157 | 41 |
| Azithromycin | Azithromycin | 155 | 123 |
| Ozempic | Semaglutide | 150 | 38 |
| Hydrochlorothiazide | Hydrochlorothiazide | 145 | 49 |
| Prednisone | Prednisone | 144 | 104 |
| Metoprolol Tartrate | Metoprolol Tartrate | 143 | 39 |
| Clonazepam | Clonazepam | 142 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 138 | 43 |
| Trazodone Hcl | Trazodone Hcl | 138 | 36 |
| Sertraline Hcl | Sertraline Hcl | 126 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 120 | 43 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 119 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 118 | 31 |
| Buspirone Hcl | Buspirone Hcl | 111 | 35 |
| Symbicort | Budesonide/Formoterol Fumarate | 110 | 37 |
| Quetiapine Fumarate | Quetiapine Fumarate | 109 | 28 |
| Doxycycline Hyclate | Doxycycline Hyclate | 108 | 83 |
| Citalopram Hbr | Citalopram Hydrobromide | 107 | 32 |
| Lamotrigine | Lamotrigine | 107 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 101 | 24 |
| Alendronate Sodium | Alendronate Sodium | 98 | 24 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 98 | 86 |
| Lorazepam | Lorazepam | 96 | 26 |
| Metformin Hcl Er | Metformin Hcl | 96 | 30 |
| Methylprednisolone | Methylprednisolone | 93 | 72 |
| Allopurinol | Allopurinol | 92 | 28 |
| Topiramate | Topiramate | 92 | 18 |
| Mounjaro | Tirzepatide | 91 | 15 |
| Fluconazole | Fluconazole | 89 | 39 |
| Ezetimibe | Ezetimibe | 88 | 20 |
| Nystatin | Nystatin | 87 | 39 |
| Mirtazapine | Mirtazapine | 81 | 21 |
| Pregabalin | Pregabalin | 79 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 79 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 76 | 18 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 72 | 22 |
| Glimepiride | Glimepiride | 72 | 23 |
| Bupropion Xl | Bupropion Hcl | 70 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 69 | 15 |
| Baclofen | Baclofen | 68 | 20 |
| Spironolactone | Spironolactone | 68 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 66 | 27 |
| Cefdinir | Cefdinir | 65 | 59 |
| Bupropion Hcl Sr | Bupropion Hcl | 63 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 62 | 26 |
| Paroxetine Hcl | Paroxetine Hcl | 62 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 62 | 11 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 61 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 61 | 38 |
| Diclofenac Sodium | Diclofenac Sodium | 60 | 25 |
| Carvedilol | Carvedilol | 59 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 29 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 25 |
| Meclizine Hcl | Meclizine Hcl | 57 | 18 |
| Clonidine Hcl | Clonidine Hcl | 56 | 20 |
| Dexamethasone | Dexamethasone | 56 | 44 |
| Ventolin Hfa | Albuterol Sulfate | 54 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 22 |
| Levetiracetam | Levetiracetam | 49 | 12 |
| Cephalexin | Cephalexin | 48 | 44 |
| Naproxen | Naproxen | 48 | 12 |
| Aripiprazole | Aripiprazole | 47 | suppressed |
| Ibuprofen | Ibuprofen | 47 | 14 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 46 | 14 |
| Doxepin Hcl | Doxepin Hcl | 46 | suppressed |
| Ondansetron Odt | Ondansetron | 46 | 23 |
| Atenolol | Atenolol | 45 | 13 |
| Bumetanide | Bumetanide | 43 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 42 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 41 | 13 |
| Risperidone | Risperidone | 41 | suppressed |
| Rybelsus | Semaglutide | 41 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 38 | 13 |
| Celecoxib | Celecoxib | 37 | 11 |
| Diazepam | Diazepam | 37 | 12 |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 36 | 24 |
| Metoclopramide Hcl | Metoclopramide Hcl | 36 | suppressed |
| Jardiance | Empagliflozin | 35 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 33 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 32 | suppressed |
| Methocarbamol | Methocarbamol | 32 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Trulicity | Dulaglutide | 32 | suppressed |
| Olanzapine | Olanzapine | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 31 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | suppressed |
| Glipizide Er | Glipizide | 30 | 11 |
| Linzess | Linaclotide | 30 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 29 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 29 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 28 | suppressed |
| Gemfibrozil | Gemfibrozil | 28 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 28 | 12 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 27 | 14 |
| Nitroglycerin | Nitroglycerin | 27 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 25 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Glipizide | Glipizide | 24 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 24 | 12 |
| Nabumetone | Nabumetone | 24 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 24 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 24 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 23 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 23 | suppressed |
| Colchicine | Colchicine | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Finasteride | Finasteride | 22 | suppressed |
| Lovastatin | Lovastatin | 22 | suppressed |
| Methimazole | Methimazole | 22 | suppressed |
| Mupirocin | Mupirocin | 22 | 17 |
| Valsartan | Valsartan | 22 | suppressed |
| Ofloxacin | Ofloxacin | 21 | 20 |
| Tresiba Flextouch U-200 | Insulin Degludec | 21 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | 11 |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Indomethacin | Indomethacin | 20 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 20 | suppressed |
| Nifedipine Er | Nifedipine | 20 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Xarelto | Rivaroxaban | 20 | suppressed |
| Invokana | Canagliflozin | 19 | suppressed |
| Lactulose | Lactulose | 19 | 11 |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 18 | 15 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 14 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 17 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 16 | 14 |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Haloperidol | Haloperidol | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Phenytoin | Phenytoin | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 14 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 13 | suppressed |
| Epinephrine | Epinephrine | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Levocarnitine | Levocarnitine | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Misoprostol | Misoprostol | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
| Valproic Acid | Valproic Acid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.70 · 1 records | Janssen Pharmaceuticals, Inc | SPRAVATO | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Janssen Pharmaceuticals, Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error